.svg)
Pharma compliance software helps pharmaceutical organizations meet the regulatory requirements governing their operations and documents, GxP disciplines, 21 CFR Part 11 for electronic records and signatures, and health-authority submission standards, through validated systems, immutable audit trails, controlled document workflows, and defensible retention across research, manufacturing, quality, and commercial functions.
Research and clinical documentation with GCP-grade control; manufacturing and quality records under GMP (batch records, SOPs, deviations, CAPAs); regulatory submissions in prescribed structures; and promotional content through MLR review. The common thread is provable integrity: every document's status, version, and approval history is itself regulated data, and the system must enforce validated processes rather than rely on staff diligence, while producing audit trails that withstand inspection.
Pharma data, research, patient, and proprietary formulation information, carries strict handling and residency requirements, so where systems and any AI run matters. Cloud is viable for many document workflows, but sensitive and sovereign-bound data often requires private-cloud, on-premises, or air-gapped deployment. AI applied to pharma content (classification, extraction, search) must run inside the compliant boundary, via bring-your-own-model where public APIs are not permissible.
ioMoVo provides audit-trailed content and document management for pharma, immutable logging, electronic signatures, controlled workflows, and AI that runs inside your boundary, deployable on-premises or air-gapped. See the ioMoVo life sciences page.
Primarily GxP (GCP, GMP, GLP), 21 CFR Part 11 for electronic records and signatures, and regional health-authority submission and pharmacovigilance requirements.
Yes, with the right controls, but sensitive and sovereign-bound data often mandates private, on-premises, or air-gapped deployment, with AI running inside that boundary.